Imperial Valley News Center
Criminalization of Dissent in Nicaragua
- Details
- Written by State Department
Washington, DC - The United States condemns the Ortega government’s recent arbitrary detention of six prominent student members of the National Dialogue. These students are the latest example of the thousands of citizens who are peacefully and democratically protesting government actions, only to be harassed, detained, disappeared, or even killed. Five of these students have been released.
U.S. Chiefs of Mission to the Dominican Republic, El Salvador, and Panama Called Back for Consultations
- Details
- Written by State Department
Washington, DC - The Department of State has called back the U.S. Ambassador to the Dominican Republic Robin Bernstein, the U.S. Ambassador to El Salvador Jean Manes, and the U.S. Charge d’Affaires in Panama Roxanne Cabral for consultations related to recent decisions to no longer recognize Taiwan.
Violence in Basrah, Iraq
- Details
- Written by State Department
Washington, DC - Under the Iraqi constitution, the right to peaceful protest and the duty to protect public and private property go hand in hand.
Congratulations to the New President of Pakistan Dr. Arif Alvi
- Details
- Written by State Department
Washington, DC - The United States and the American people congratulate Dr. Arif Alvi on his swearing in as the new President of the Islamic Republic of Pakistan.
Dairy Digester Research and Development Program
- Details
- Written by IVN
Sacramento, California - Two public stakeholder workshops and one webinar are scheduled during September 2018 to assist applicants to the Dairy Digester Research and Development Program (DDRDP). The aim of these workshops is to introduce dairy producers, new project developers, and other interested parties to the DDRDP and assist in improving the competitiveness of applications by reviewing common errors and issues.
FDA approves new dosage strength of buprenorphine and naloxone sublingual film as maintenance treatment for opioid dependence
- Details
- Written by Michael Felberbaum
Washington, DC - The U.S. Food and Drug Administration today approved Cassipa (buprenorphine and naloxone) sublingual film (applied under the tongue) for the maintenance treatment of opioid dependence. This action provides a new dosage strength (16 milligrams/4 milligrams) of buprenorphine and naloxone sublingual film, which is also approved in both brand name and generic versions and in various strengths.
Page 1106 of 3785